The Impact of Cardiovascular Disease Prevalence on the U.S. Simvastatin Market In the United States, simvastatin remains one of the most commonly prescribed statins for managing high cholesterol and reducing the risk of cardiovascular diseases, including heart attacks and strokes. The growing prevalence of obesity, diabetes, hypertension, and sedentary lifestyles has increased the need for effective lipid-lowering therapies. Strong clinical guidelines, widespread...